IN THE NEWS: FDA Finalizes Guidance to Broaden Cancer Clinical Trial Eligibility

Oncology Times

New guidance documents released by the FDA's Oncology Center of Excellence, in collaboration with the American Society of Clinical Oncology and Friends of Cancer Research, look to close the gap between the number of patients who are currently enrolled in clinical trials and the number of patients who would participate in a clinical trial if they were asked. These guidelines address barriers and patient qualification. Boris Pasche, M.D., Ph.D., FACP, president and CEO of Karmanos, provided insight into why these guidelines will help make trials more inclusive and representative of the patients who will need these novel therapies in the future, and how they will lead to greater clinical trial accrual.

Read the article here.